Not all patients with CLL require therapy. In spite of all new advancements, the iwCLL still recommends watchful observation for individuals with asymptomatic illness.86 This advice relies on at the least two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). MPO777 menyediakan layanan pelanggan https://link-alternatif-mbl7799987.qowap.com/92339504/about-link-alternatif-mbl77